6753:TSESharp Corporation Analysis
Data as of 2026-06-13 - not real-time
¥609.20
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Sharp Corp's current price of 609.2 JPY sits below the 20‑day SMA of 632.8, indicating a short‑term drag. The 50‑day SMA of 609.1 aligns closely with the price, suggesting a potential stabilization point. However, the 200‑day SMA of 731.2 remains far above, keeping the long‑term trend neutral. RSI at 45.3 signals moderate weakness, hovering just below the 50‑range. The MACD shows a bearish signal, with the histogram –3.7 and the line crossing below the signal line. Volume is on a decreasing trend, adding pressure to the downward trajectory.
The price is trapped between a support level of 600 and a resistance of 681.6, with the current price edging the support. The 30‑day volatility of 48% and a max drawdown of –38.7% indicate a highly volatile environment. The company's PE ratio of 8.34 is dramatically lower than the industry average of 36.83, suggesting the stock is undervalued. Yet, revenue has contracted by 5.4% YoY and operating cash flow is negative, tempering growth expectations. Debt‑to‑equity stands at an extreme 148, indicating a heavy debt load that could strain future earnings. The fear‑greed index sits at 89.86, labeled “Extreme Greed,” indicating market euphoria that may mask underlying risks.
The price is trapped between a support level of 600 and a resistance of 681.6, with the current price edging the support. The 30‑day volatility of 48% and a max drawdown of –38.7% indicate a highly volatile environment. The company's PE ratio of 8.34 is dramatically lower than the industry average of 36.83, suggesting the stock is undervalued. Yet, revenue has contracted by 5.4% YoY and operating cash flow is negative, tempering growth expectations. Debt‑to‑equity stands at an extreme 148, indicating a heavy debt load that could strain future earnings. The fear‑greed index sits at 89.86, labeled “Extreme Greed,” indicating market euphoria that may mask underlying risks.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Bearish MACD signal
- Decreasing volume trend
- Price near support level
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Undervalued valuation (low PE)
- Neutral technical trend
- Modest upside potential (≈5%)
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Low PE vs industry
- Strong ROE (~20%)
- Diversified product portfolio across multiple segments
Key Metrics & Analysis
Financial Health
Revenue Growth-5.40%
Profit Margin2.51%
P/E Ratio8.3
ROE20.86%
ROA2.11%
Debt/Equity148.00
P/B Ratio1.4
Op. Cash Flow¥-191000000
Free Cash Flow¥-15484874752
Industry P/E36.8
Technical Analysis
TrendNeutral
RSI45.3
Support¥600.00
Resistance¥681.60
MA 20¥632.83
MA 50¥609.15
MA 200¥731.21
MACDBearish
VolumeDecreasing
Fear & Greed Index89.86
Valuation
Target Price¥641.25
Upside/Downside5.26%
GradeUndervalued
TypeBlend
Risk Assessment
Beta0.39
Volatility48.21%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.